106 related articles for article (PubMed ID: 9434633)
1. Transcriptional repression by the promyelocytic leukemia protein, PML.
Vallian S; Gäken JA; Trayner ID; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Exp Cell Res; 1997 Dec; 237(2):371-82. PubMed ID: 9434633
[TBL] [Abstract][Full Text] [Related]
2. The PML-RAR alpha gene product of the t(15;17) translocation inhibits retinoic acid-induced granulocytic differentiation and mediated transactivation in human myeloid cells.
Rousselot P; Hardas B; Patel A; Guidez F; Gäken J; Castaigne S; Dejean A; de Thé H; Degos L; Farzaneh F
Oncogene; 1994 Feb; 9(2):545-51. PubMed ID: 8290265
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Fos-mediated AP-1 transcription by the promyelocytic leukemia protein.
Vallian S; Gäken JA; Gingold EB; Kouzarides T; Chang KS; Farzaneh F
Oncogene; 1998 Jun; 16(22):2843-53. PubMed ID: 9671405
[TBL] [Abstract][Full Text] [Related]
4. The PML-retinoic acid receptor alpha translocation converts the receptor from an inhibitor to a retinoic acid-dependent activator of transcription factor AP-1.
Doucas V; Brockes JP; Yaniv M; de Thé H; Dejean A
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9345-9. PubMed ID: 8415704
[TBL] [Abstract][Full Text] [Related]
5. Transcriptional activation of the cyclin-dependent kinase inhibitor p21 by PML/RARalpha.
Yang WL; Zeng YX; El-Deiry WS; Nason-Burchenal K; Dmitrovsky E; Chin KV
Mol Cell Biol Res Commun; 1999 May; 1(2):125-31. PubMed ID: 10356361
[TBL] [Abstract][Full Text] [Related]
6. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Dejean A
Leukemia; 1994 Oct; 8(10):1615-21. PubMed ID: 7934155
[TBL] [Abstract][Full Text] [Related]
7. Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.
Grignani F; De Matteis S; Nervi C; Tomassoni L; Gelmetti V; Cioce M; Fanelli M; Ruthardt M; Ferrara FF; Zamir I; Seiser C; Grignani F; Lazar MA; Minucci S; Pelicci PG
Nature; 1998 Feb; 391(6669):815-8. PubMed ID: 9486655
[TBL] [Abstract][Full Text] [Related]
8. The promyelocytic leukemia protein interacts with Sp1 and inhibits its transactivation of the epidermal growth factor receptor promoter.
Vallian S; Chin KV; Chang KS
Mol Cell Biol; 1998 Dec; 18(12):7147-56. PubMed ID: 9819401
[TBL] [Abstract][Full Text] [Related]
9. Effect of the acute promyelocytic leukemia PML/RAR alpha protein on differentiation and survival of myeloid precursors.
Fagioli M; Grignani F; Ferrucci PF; Alcalay M; Mencarelli A; Nicoletti I; Grignani F; Pelicci PG
Leukemia; 1994 Apr; 8 Suppl 1():S7-11. PubMed ID: 8152308
[TBL] [Abstract][Full Text] [Related]
10. The t(15;17) translocation in acute promyelocytic leukemia.
Lavau C; Jansen J; Dejean A
Pathol Biol (Paris); 1995 Mar; 43(3):188-96. PubMed ID: 7675545
[TBL] [Abstract][Full Text] [Related]
11. Promyelocytic leukemia-specific PML-retinoic acid alpha receptor fusion protein interferes with erythroid differentiation of human erythroleukemia K562 cells.
Grignani F; Testa U; Fagioli M; Barberi T; Masciulli R; Mariani G; Peschle C; Pelicci PG
Cancer Res; 1995 Jan; 55(2):440-3. PubMed ID: 7529139
[TBL] [Abstract][Full Text] [Related]
12. Effect of PML and PML-RAR on the transactivation properties and subcellular distribution of steroid hormone receptors.
Guiochon-Mantel A; Savouret JF; Quignon F; Delabre K; Milgrom E; De The H
Mol Endocrinol; 1995 Dec; 9(12):1791-803. PubMed ID: 8614415
[TBL] [Abstract][Full Text] [Related]
13. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML.
Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E
Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078
[TBL] [Abstract][Full Text] [Related]
14. Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.
He LZ; Guidez F; Tribioli C; Peruzzi D; Ruthardt M; Zelent A; Pandolfi PP
Nat Genet; 1998 Feb; 18(2):126-35. PubMed ID: 9462740
[TBL] [Abstract][Full Text] [Related]
15. Accelerated degradation of PML-retinoic acid receptor alpha (PML-RARA) oncoprotein by all-trans-retinoic acid in acute promyelocytic leukemia: possible role of the proteasome pathway.
Yoshida H; Kitamura K; Tanaka K; Omura S; Miyazaki T; Hachiya T; Ohno R; Naoe T
Cancer Res; 1996 Jul; 56(13):2945-8. PubMed ID: 8674046
[TBL] [Abstract][Full Text] [Related]
16. PMLRAR homodimers: distinct DNA binding properties and heteromeric interactions with RXR.
Perez A; Kastner P; Sethi S; Lutz Y; Reibel C; Chambon P
EMBO J; 1993 Aug; 12(8):3171-82. PubMed ID: 8393784
[TBL] [Abstract][Full Text] [Related]
17. Molecular analysis of the PML/RAR alpha chimeric gene in pediatric acute promyelocytic leukemia.
Kane JR; Head DR; Balazs L; Hulshof MG; Motroni TA; Raimondi SC; Carroll AJ; Behm FG; Krance RA; Shurtleff SA; Downing JR
Leukemia; 1996 Aug; 10(8):1296-302. PubMed ID: 8709634
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional regulation is affected by subnuclear targeting of reporter plasmids to PML nuclear bodies.
Block GJ; Eskiw CH; Dellaire G; Bazett-Jones DP
Mol Cell Biol; 2006 Dec; 26(23):8814-25. PubMed ID: 16966371
[TBL] [Abstract][Full Text] [Related]
19. Retinoic acid regulatory pathways, chromosomal translocations, and acute promyelocytic leukemia.
Chen Z; Tong JH; Dong S; Zhu J; Wang ZY; Chen SJ
Genes Chromosomes Cancer; 1996 Mar; 15(3):147-56. PubMed ID: 8721678
[TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: from clinic to molecular biology.
Chen SJ; Wang ZY; Chen Z
Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]